Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
Explore this paper's citation graph
Summary
GCDFP-15 expression is further a frequent feature of AR positive tumors and the molecular apocrine subtype, and it might have reduced sensitivity as a diagnostic marker for mammary differentiation in triple negative tumors as compared to HR or HER2 positive tumor types.
- Type
- dissertation
- Published
- 2014-07-28
- Cited by
- 82
- References
- 30
- Access
- Open access
- OpenAlex
- https://openalex.org/W25070172
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9482049
Keywords
Internalization, HEK 293 cells, GABAB receptor, Cell biology, Receptor
References
- Apocrine carcinoma of the breast: a comprehensive review.
- Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
- Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
- Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.
- Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
- A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer
- Expression of GCDFP‐15 and AR decreases in larger or node‐positive apocrine carcinomas of the breast
- Evaluation of a Breast Cyst Fluid Protein Detectable in the Plasma of Breast Carcinoma Patients
- PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
- Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein‐15 as markers of apocrine carcinoma of the breast
- Regulation of GCDFP-15 expression in human mammary cancer cells.
- Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.
- GCDFP-15 and Mammaglobin Expression by Immunohistochemistry is of Limited Utility in Triple-Negative Breast Cancer
- Relationship Between Molecular Subtype of Invasive Breast Carcinoma and Expression of Gross Cystic Disease Fluid Protein 15 and Mammaglobin
- In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.
- Response-guided neoadjuvant chemotherapy for breast cancer.
- Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Cited by
- Molecular and diagnostic features of apocrine breast lesions
- Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes
- Androgen Receptor (AR) and Breast Cancer: Reference to the AR Status in Normal/Benign Breast Luminal Cells
- GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
- Gross Cystic Disease Fluid Protein 15 in Stratum Corneum Is a Potential Marker of Decreased Eccrine Sweating for Atopic Dermatitis
- Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago
- Translational Research and Plasma Proteomic in Cancer
- Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer
- Increased peri-ductal collagen micro-organization may contribute to raised mammographic density
- Markers of metastatic carcinoma of breast origin
- Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.
- Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator—Novel Insights from Knockout Mice
- GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
- Strong Correlation of Indoleamine 2,3-Dioxygenase 1 Expression with Basal-Like Phenotype and Increased Lymphocytic Infiltration in Triple-Negative Breast Cancer
- Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5
- Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes
- GATA3 as a putative marker of breast cancer metastasis—A retrospective immunohistochemical study
- Dimorphic variant of ductal carcinoma in situ of the breast
- Functional proteomics outlines the complexity of breast cancer molecular subtypes
- Clinicopathological study of a dimorphic variant of breast carcinoma
Related papers
- Endoplasmic Reticulum Sorting and Kinesin-1 Command the Targeting of Axonal GABAB Receptors
- Inhibitory Signaling to Ion Channels in Hippocampal Neurons Is Differentially Regulated by Alternative Macromolecular Complexes of RGS7
- N‐glycosylation of the AMPA‐type glutamate receptor regulates cell surface expression and tetramer formation affecting channel function
- GABAAR isoform and subunit structural motifs determine synaptic and extrasynaptic receptor localisation.
- Regulation of inhibitory synaptic transmission by a conserved atypical AP2 interaction within GABAA receptor β and γ subunits
- Directing AMPA receptor traffic.